NEW YORK (
CHANGE IN RATINGS
(AWRE) was downgraded to hold at TheStreet Ratings.
(CRM - Get Report) was downgraded at Wedbush to neutral from outperform. $42 price target. Lower sales commission suggests lower new sales activity, Wedbush said.
(CRUS - Get Report) was downgraded at Canaccord Genuity to hold from buy. $18 price target. Pricing and margins are coming under pressure, Canaccord said.
was downgraded at JMP Securities to underperform from market perform. $8 price target. Business fundamentals are deteriorating, which is cutting into earnings quality, JMP said.
(NDSN - Get Report)
was downgraded to market perform from outperform at BMO Capital. $72 price target. Company cut guidance and is seeing lower order growth, BMO Capital said.
Nordson was downgraded at Oppenheimer to perform from outperform. Company lacks medium-term catalysts, Oppenheimer said.
was downgraded to hold at TheStreet Ratings.
Procter & Gamble
(PG - Get Report)
was upgraded at UBS to buy from neutral. AG Lafley returns to the helm as CEO, said UBS. Price target goes to $95.
(SHW - Get Report)
was upgraded at Robert Baird to outperform from neutral. $205 price target. Company had a solid analyst meeting and appears ready to post several years of earnings outperformance, Robert Baird said.
STOCK COMMENTS / EPS CHANGES
Advanced Auto Parts
estimates raised at UBS, as weather trends are expected to improve and guidance is viewed as conservative, said UBS.
numbers lowered at Credit Suisse. Shares of ATI now seen reaching $31, Credit Suisse said. Estimates also lowered as near term confidence wanes on FRP. Neutral rating.
price target and estimates raised at UBS. The company is seeing good initial traction for DNS, is increasing total addressable market into security, and is in the early stages of product adoption. Price target goes to $28.
price target raised at Credit Suisse to $77; reflects the spin out of Knowles as the company's business mix has changed materially, said Credit Suisse.
price target and estimates raised at UBS. GPS earnings estimates were increased to reflect a recovering consumer, improved full-priced selling and the omni-channel opportunity, said UBS. Price target goes to $41.